[The contribution of drug research to the understanding of schizophrenia].
D000328:Adult; D000662:Amphetamines / Q000494:pharmacology; D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology; D001418:Baclofen / Q000627:therapeutic use; D002746:Chlorpromazine / Q000494:pharmacology; D003342:Corpus Striatum / Q000187:drug effects; D004298:Dopamine / Q000494:pharmacology; D006220:Haloperidol / Q000494:pharmacology; D006801:Humans; D008032:Limbic System / Q000187:drug effects; D008297:Male; D008781:Methyltyrosines / Q000627:therapeutic use; D009638:Norepinephrine / Q000378:metabolism; D051381:Rats; D012110:Reserpine / Q000378:metabolism; D012559:Schizophrenia / Q000378:metabolism*; D009435:Synaptic Transmission; D013881:Thioridazine / Q000627:therapeutic use; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism; D005680:gamma-Aminobutyric Acid / Q000494:pharmacology
D000662:Amphetamines; D014150:Antipsychotic Agents; D008781:Methyltyrosines; D005680:gamma-Aminobutyric Acid; D012110:Reserpine; D014446:Tyrosine 3-Monooxygenase; D001418:Baclofen; D006220:Haloperidol; D013881:Thioridazine; D002746:Chlorpromazine; D004298:Dopamine; D009638:Norepinephrine
Der Beitrag der Arzneimittelforschung zum Verständnis der Schizophrenie